<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087981</url>
  </required_header>
  <id_info>
    <org_study_id>Renjineuro-BDA(2017)</org_study_id>
    <nct_id>NCT03087981</nct_id>
  </id_info>
  <brief_title>Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition</brief_title>
  <acronym>PANDA</acronym>
  <official_title>A Multicenter Prospective Observational Study to Analyze Various ICP Derived Parameters and Clinical Status in Neurosurgical Critical Patients Through Big Data Acquisition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PANDA trial is a multicenter prospective observational study designed to analyze various
      ICP derived parameters and clinical status in neurosurgical critical patients through a new
      big data acquisition system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nowadays, intracranial pressure (ICP) monitoring is widely used as a way to evaluate
      intracranial status in neurosurgery department especially in neurosurgical critical patients.
      Most of us focus only on the mean ICP value while ignoring other ICP derived parameters, such
      ICP waveform, AMP, RAP, PRx, IAAC and so on. However, it is reported that these parameters
      can reflect the status of intracerebral circulation, cerebrospinal compensatory reserve and
      brain compliance and can often be indicative of impending neurological deterioration and even
      outcome of patients. The PANDA trial is a multicenter prospective observational study
      designed to investigate the relationship between these ICP derived parameters and clinical
      status and to uncover the mechanism behind it. We will use a brand-new automatic big data
      collecting and storing system to continuously acquire patients' physiological information
      such as blood pressure, ICP, ETCO2ï¼ŒEEG etc. before analysis. Hopefully, this trial will
      reveal what is happening in the cranial cavity through the natural history of different kinds
      of intracranial lesion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glasgow Outcome Scale(GOS)</measure>
    <time_frame>within 3 months after enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Glasgow Coma Scale(GCS)</measure>
    <time_frame>within 3 months after enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability Rating Scale (DRS)</measure>
    <time_frame>within 3 months after enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean intracranial pressure(ICP) value</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between pulse amplitude and mean intracranial pressure(RAP)</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure-reactivity index(PRx)</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse amplitude of ICP(AMP)</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ICP-arterial blood pressure(ABP) wave amplitude correlation(IAAC)</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral perfusion pressure(CPP)</measure>
    <time_frame>throughout ICP monitoring, average 7 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Intracranial Pressure</condition>
  <condition>Neurosurgery</condition>
  <condition>Information Management</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with intracranial lesion
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65 years old

          -  Intracranial lesion underwent ICP sensor implantation

          -  Informed consent obtained

        Exclusion Criteria:

          -  No consent

          -  A life-threatening injury to an organ other than the brain

          -  Known pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guoyi Gao, Dr.</last_name>
    <phone>+86-021-68383709</phone>
    <email>guoyigao@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guoyi Gao, M.D.</last_name>
      <phone>+86-021-68383709</phone>
      <email>guoyigao@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Guoyi Gao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Di Ieva A, Schmitz EM, Cusimano MD. Analysis of intracranial pressure: past, present, and future. Neuroscientist. 2013 Dec;19(6):592-603. doi: 10.1177/1073858412474845. Epub 2013 Feb 6. Review.</citation>
    <PMID>23389057</PMID>
  </reference>
  <reference>
    <citation>Eide PK, Sorteberg A, Bentsen G, Marthinsen PB, Stubhaug A, Sorteberg W. Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2012 May;116(5):961-71. doi: 10.3171/2012.1.JNS111313. Epub 2012 Feb 10.</citation>
    <PMID>22324419</PMID>
  </reference>
  <reference>
    <citation>Czosnyka M, Smielewski P, Timofeev I, Lavinio A, Guazzo E, Hutchinson P, Pickard JD. Intracranial pressure: more than a number. Neurosurg Focus. 2007 May 15;22(5):E10.</citation>
    <PMID>17613228</PMID>
  </reference>
  <reference>
    <citation>Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):813-21. Review.</citation>
    <PMID>15145991</PMID>
  </reference>
  <reference>
    <citation>Hamilton R, Xu P, Asgari S, Kasprowicz M, Vespa P, Bergsneider M, Hu X. Forecasting intracranial pressure elevation using pulse waveform morphology. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4331-4. doi: 10.1109/IEMBS.2009.5332749.</citation>
    <PMID>19963821</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2017</study_first_submitted>
  <study_first_submitted_qc>March 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2017</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

